---
{"dg-publish":true,"permalink":"/research/tags/beta-hydroxybutyrate-bhb/","updated":"2025-01-30T15:46:48-05:00"}
---

# Tagged Content
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Takeaways</span><span class="dataview small-text">3</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-02-02 15-23-28.md" data-href="Research/Takeaways/2025-02-02 15-23-28.md" href="Research/Takeaways/2025-02-02 15-23-28.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-02-02 15-23-28</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> can protect against <a data-href="Hypoglycemia" href="Hypoglycemia" class="internal-link" target="_blank" rel="noopener nofollow">Hypoglycemia</a>-induced reductions in <a data-href="Cognitive Performance" href="Cognitive Performance" class="internal-link" target="_blank" rel="noopener nofollow">Cognitive Performance</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-31 15-33-37.md" data-href="Research/Takeaways/2025-01-31 15-33-37.md" href="Research/Takeaways/2025-01-31 15-33-37.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 15-33-37</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Following a <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> with blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels ~1.4-2.0 mM intermittently may be better than following it continuously, regardless of protein intake, due to the accumulation of <a data-href="Senescent Cells" href="Senescent Cells" class="internal-link" target="_blank" rel="noopener nofollow">Senescent Cells</a>.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-31 14-37-21.md" data-href="Research/Takeaways/2025-01-31 14-37-21.md" href="Research/Takeaways/2025-01-31 14-37-21.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 14-37-21</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A protein-restricted <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> may reduce the progression of <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> when blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels are maintained ~3.0 mM and there is no weight loss.</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">12</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-22-21.md" data-href="Research/Insights/2025-01-30 12-22-21.md" href="Research/Insights/2025-01-30 12-22-21.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-22-21</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Mice have a blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> level of ~2.25 mM after 48 hours of <a data-href="Prolonged Fasting" href="Prolonged Fasting" class="internal-link" target="_blank" rel="noopener nofollow">Prolonged Fasting</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 20-41-50.md" data-href="Research/Insights/2025-01-20 20-41-50.md" href="Research/Insights/2025-01-20 20-41-50.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 20-41-50</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Fewer <a data-href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" class="internal-link" target="_blank" rel="noopener nofollow">Muscle Stem Cells (MuSCs, Satellite Stem Cells)</a> from mice treated with intraperitoneal injections of 200 mg/kg/day <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> + 200 mg/kg/day <a data-href="Acetoacetate (AcAc)" href="Acetoacetate (AcAc)" class="internal-link" target="_blank" rel="noopener nofollow">Acetoacetate (AcAc)</a> are in <a data-href="S Phase" href="S Phase" class="internal-link" target="_blank" rel="noopener nofollow">S Phase</a> compared to control mice as assessed by Edu incorporation</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 20-37-16.md" data-href="Research/Insights/2025-01-20 20-37-16.md" href="Research/Insights/2025-01-20 20-37-16.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 20-37-16</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Fewer <a data-href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" class="internal-link" target="_blank" rel="noopener nofollow">Muscle Stem Cells (MuSCs, Satellite Stem Cells)</a> enter <a data-href="S Phase" href="S Phase" class="internal-link" target="_blank" rel="noopener nofollow">S Phase</a> when cultured ex vivo when the stem cells are isolated from mice treated with 3x/day intraperitoneal injections of 200 mg/kg <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> + 200 mg/kg <a data-href="Acetoacetate (AcAc)" href="Acetoacetate (AcAc)" class="internal-link" target="_blank" rel="noopener nofollow">Acetoacetate (AcAc)</a> compared to control mice as assessed by <a data-href="EdU" href="EdU" class="internal-link" target="_blank" rel="noopener nofollow">EdU</a> incorporation</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 20-32-54.md" data-href="Research/Insights/2025-01-20 20-32-54.md" href="Research/Insights/2025-01-20 20-32-54.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 20-32-54</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" class="internal-link" target="_blank" rel="noopener nofollow">Muscle Stem Cells (MuSCs, Satellite Stem Cells)</a> exhibit reduced basal oxygen consumption at the end of 7 days of 3x/day intraperitoneal 200 mg/kg <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> + 200 mg/kg <a data-href="Acetoacetate (AcAc)" href="Acetoacetate (AcAc)" class="internal-link" target="_blank" rel="noopener nofollow">Acetoacetate (AcAc)</a> injections in mice compared with control mice</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 20-19-43.md" data-href="Research/Insights/2025-01-20 20-19-43.md" href="Research/Insights/2025-01-20 20-19-43.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 20-19-43</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" class="internal-link" target="_blank" rel="noopener nofollow">Muscle Stem Cells (MuSCs, Satellite Stem Cells)</a> have reduced content of <a data-href="Mitochondria" href="Mitochondria" class="internal-link" target="_blank" rel="noopener nofollow">Mitochondria</a> (number and/or size) in mice at the end of 7 days of 3x/day intraperitoneal 200 mg/kg <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> + 200 mg/kg <a data-href="Acetoacetate (AcAc)" href="Acetoacetate (AcAc)" class="internal-link" target="_blank" rel="noopener nofollow">Acetoacetate (AcAc)</a> injections compared to control mice as assessed by <a data-href="MitoTracker" href="MitoTracker" class="internal-link" target="_blank" rel="noopener nofollow">MitoTracker</a> and <a data-href="MitoSox" href="MitoSox" class="internal-link" target="_blank" rel="noopener nofollow">MitoSox</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 20-12-30.md" data-href="Research/Insights/2025-01-20 20-12-30.md" href="Research/Insights/2025-01-20 20-12-30.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 20-12-30</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" href="Muscle Stem Cells (MuSCs, Satellite Stem Cells)" class="internal-link" target="_blank" rel="noopener nofollow">Muscle Stem Cells (MuSCs, Satellite Stem Cells)</a> enter a state of <a data-href="Deep Quiescence" href="Deep Quiescence" class="internal-link" target="_blank" rel="noopener nofollow">Deep Quiescence</a> at the end of 1 week of 3x/day intraperitoneal injections of 200 mg/kg <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> + 200 mg/kg <a data-href="Acetoacetate (AcAc)" href="Acetoacetate (AcAc)" class="internal-link" target="_blank" rel="noopener nofollow">Acetoacetate (AcAc)</a> in mice</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 16-46-34.md" data-href="Research/Insights/2025-01-20 16-46-34.md" href="Research/Insights/2025-01-20 16-46-34.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 16-46-34</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Mice following a <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> for 20 days have a blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> level of ~2.1 mM</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 16-08-05.md" data-href="Research/Insights/2025-01-20 16-08-05.md" href="Research/Insights/2025-01-20 16-08-05.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 16-08-05</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The capacity of mouse muscle for <a data-href="Regeneration" href="Regeneration" class="internal-link" target="_blank" rel="noopener nofollow">Regeneration</a> may be reduced when blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels are ~2.25 mM at the time of injury compared to ~1.9-2.25 mM</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 16-01-27.md" data-href="Research/Insights/2025-01-20 16-01-27.md" href="Research/Insights/2025-01-20 16-01-27.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 16-01-27</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The capability of mouse muscle for <a data-href="Regeneration" href="Regeneration" class="internal-link" target="_blank" rel="noopener nofollow">Regeneration</a> may be reduced when blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels are ~1.9-2.25 mM at the time of injury compared to ~0.4 mM</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 15-44-11.md" data-href="Research/Insights/2025-01-20 15-44-11.md" href="Research/Insights/2025-01-20 15-44-11.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 15-44-11</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Mice have a blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> level of ~2.75 mM after 60 hours of <a data-href="Prolonged Fasting" href="Prolonged Fasting" class="internal-link" target="_blank" rel="noopener nofollow">Prolonged Fasting</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 15-42-14.md" data-href="Research/Insights/2025-01-20 15-42-14.md" href="Research/Insights/2025-01-20 15-42-14.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 15-42-14</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Mice fasting for 24 hours have a blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> level of ~1.9 mM</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-20 15-39-52.md" data-href="Research/Insights/2025-01-20 15-39-52.md" href="Research/Insights/2025-01-20 15-39-52.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 15-39-52</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Non-fasting mice can have a resting blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> level of ~0.4 mM</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Quick Notes</span><span class="dataview small-text">14</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-02-02 15-20-05.md" data-href="Research/Quick Notes/2025-02-02 15-20-05.md" href="Research/Quick Notes/2025-02-02 15-20-05.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-02-02 15-20-05</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Cognitive Performance" href="Cognitive Performance" class="internal-link" target="_blank" rel="noopener nofollow">Cognitive Performance</a> during <a data-href="Hypoglycemia" href="Hypoglycemia" class="internal-link" target="_blank" rel="noopener nofollow">Hypoglycemia</a> is not reduced in people with <a data-href="Type 1 Diabetes" href="Type 1 Diabetes" class="internal-link" target="_blank" rel="noopener nofollow">Type 1 Diabetes</a> when they take <a data-href="Medium Chain Triglycerides (MCTs)" href="Medium Chain Triglycerides (MCTs)" class="internal-link" target="_blank" rel="noopener nofollow">Medium Chain Triglycerides (MCTs)</a> during hypoglycemia due to an increase in plasma <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-02-02 15-15-56.md" data-href="Research/Quick Notes/2025-02-02 15-15-56.md" href="Research/Quick Notes/2025-02-02 15-15-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-02-02 15-15-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Synaptic activity of rat hippocampal brain slices is improved by <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> during <a data-href="Hypoglycemia" href="Hypoglycemia" class="internal-link" target="_blank" rel="noopener nofollow">Hypoglycemia</a> <em>in vitro</em> </span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-02-02 14-53-51.md" data-href="Research/Quick Notes/2025-02-02 14-53-51.md" href="Research/Quick Notes/2025-02-02 14-53-51.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-02-02 14-53-51</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Medium Chain Triglycerides (MCTs)" href="Medium Chain Triglycerides (MCTs)" class="internal-link" target="_blank" rel="noopener nofollow">Medium Chain Triglycerides (MCTs)</a> increase plasma levels of <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> in people with <a data-href="Type 1 Diabetes" href="Type 1 Diabetes" class="internal-link" target="_blank" rel="noopener nofollow">Type 1 Diabetes</a> even when plasma <a data-href="Insulin" href="Insulin" class="internal-link" target="_blank" rel="noopener nofollow">Insulin</a> levels are increased</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-02-02 12-15-01.md" data-href="Research/Quick Notes/2025-02-02 12-15-01.md" href="Research/Quick Notes/2025-02-02 12-15-01.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-02-02 12-15-01</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels increase to ~2.2 mM after 60 hours of <a data-href="Fasting" href="Fasting" class="internal-link" target="_blank" rel="noopener nofollow">Fasting</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 16-36-26.md" data-href="Research/Quick Notes/2025-01-31 16-36-26.md" href="Research/Quick Notes/2025-01-31 16-36-26.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 16-36-26</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Following a <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> continuously for 6 months while maintaining blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels between 0.5-3.0 mM can increase circulating markers of <a data-href="Senescence-Associated Secretory Phenotype" href="Senescence-Associated Secretory Phenotype" class="internal-link" target="_blank" rel="noopener nofollow">Senescence-Associated Secretory Phenotype</a>.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 16-13-08.md" data-href="Research/Quick Notes/2025-01-31 16-13-08.md" href="Research/Quick Notes/2025-01-31 16-13-08.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 16-13-08</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><em>In vitro</em> exposure of <a data-href="Human Umbilical Vein Endothelial Cells (HUVECs)" href="Human Umbilical Vein Endothelial Cells (HUVECs)" class="internal-link" target="_blank" rel="noopener nofollow">Human Umbilical Vein Endothelial Cells (HUVECs)</a> to 4 mM <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> induces <a data-href="Quiescence" href="Quiescence" class="internal-link" target="_blank" rel="noopener nofollow">Quiescence</a>.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 16-08-45.md" data-href="Research/Quick Notes/2025-01-31 16-08-45.md" href="Research/Quick Notes/2025-01-31 16-08-45.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 16-08-45</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><em>In vitro</em> exposure of <a data-href="Human Umbilical Vein Endothelial Cells (HUVECs)" href="Human Umbilical Vein Endothelial Cells (HUVECs)" class="internal-link" target="_blank" rel="noopener nofollow">Human Umbilical Vein Endothelial Cells (HUVECs)</a> to 4 mM <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> reduces the accumulation of <a data-href="Senescent Cells" href="Senescent Cells" class="internal-link" target="_blank" rel="noopener nofollow">Senescent Cells</a>.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 16-05-19.md" data-href="Research/Quick Notes/2025-01-31 16-05-19.md" href="Research/Quick Notes/2025-01-31 16-05-19.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 16-05-19</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><em>In vitro</em> exposure to 4 mM <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> reduces the percentage of <a data-href="Human Umbilical Vein Endothelial Cells (HUVECs)" href="Human Umbilical Vein Endothelial Cells (HUVECs)" class="internal-link" target="_blank" rel="noopener nofollow">Human Umbilical Vein Endothelial Cells (HUVECs)</a> in <a data-href="S Phase" href="S Phase" class="internal-link" target="_blank" rel="noopener nofollow">S Phase</a>.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 16-03-29.md" data-href="Research/Quick Notes/2025-01-31 16-03-29.md" href="Research/Quick Notes/2025-01-31 16-03-29.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 16-03-29</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><em>In vitro</em> exposure to 4 mM <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> increases the percentage of <a data-href="Human Umbilical Vein Endothelial Cells (HUVECs)" href="Human Umbilical Vein Endothelial Cells (HUVECs)" class="internal-link" target="_blank" rel="noopener nofollow">Human Umbilical Vein Endothelial Cells (HUVECs)</a> in <a data-href="G0 Phase" href="G0 Phase" class="internal-link" target="_blank" rel="noopener nofollow">G0 Phase</a>.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 15-16-59.md" data-href="Research/Quick Notes/2025-01-31 15-16-59.md" href="Research/Quick Notes/2025-01-31 15-16-59.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 15-16-59</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> can cause the accumulation of <a data-href="Senescence-Associated Beta-Galactosidase (SA-β-gal)" href="Senescence-Associated Beta-Galactosidase (SA-β-gal)" class="internal-link" target="_blank" rel="noopener nofollow">Senescence-Associated Beta-Galactosidase (SA-β-gal)</a>/<a data-href="Senescent Cells" href="Senescent Cells" class="internal-link" target="_blank" rel="noopener nofollow">Senescent Cells</a> in multiple organs in mice compared to a control diet independent of weight when <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels are maintained ~1.4-1.8 mM in the ketogenic group and ~0.8-1.0 mM in the control group. Ketogenic diet protein composition 10% of calories and control diet protein composition 10% of calories.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 14-40-42.md" data-href="Research/Quick Notes/2025-01-31 14-40-42.md" href="Research/Quick Notes/2025-01-31 14-40-42.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 14-40-42</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> can cause the accumulation of <a data-href="Senescence-Associated Beta-Galactosidase (SA-β-gal)" href="Senescence-Associated Beta-Galactosidase (SA-β-gal)" class="internal-link" target="_blank" rel="noopener nofollow">Senescence-Associated Beta-Galactosidase (SA-β-gal)</a>/<a data-href="Senescent Cells" href="Senescent Cells" class="internal-link" target="_blank" rel="noopener nofollow">Senescent Cells</a> in multiple organs in mice compared to a control diet independent of weight when blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels are maintained ~1.4-2.0 mM in the ketogenic diet group and ~0.8-0.9 mM in the control group. Ketogenic diet protein composition 9.2% of calories vs. control diet protein composition 25% of calories.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 14-23-42.md" data-href="Research/Quick Notes/2025-01-31 14-23-42.md" href="Research/Quick Notes/2025-01-31 14-23-42.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 14-23-42</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span> A <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> can worsen the progression of <a data-href="Knee" href="Knee" class="internal-link" target="_blank" rel="noopener nofollow">Knee</a> <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in mice who maintain <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels ~ 1.28 mM compared to control rats with BHB levels ~0.87 mM when ketogenic-diet-fed mice lose weight post-injury and control mice do not. This is potentially due to ketogenic-diet-induced changes in the <a data-tooltip-position="top" aria-label="Research/Tags/Gut Microbiome" data-href="Research/Tags/Gut Microbiome" href="Research/Tags/Gut Microbiome" class="internal-link" target="_blank" rel="noopener nofollow">Gut Microbiome</a>. Ketogenic diet protein composition 22.4% of calories and control diet protein composition 24% of calories.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-28 19-22-32.md" data-href="Research/Quick Notes/2025-01-28 19-22-32.md" href="Research/Quick Notes/2025-01-28 19-22-32.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 19-22-32</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> can reduce the progression of <a data-href="Knee" href="Knee" class="internal-link" target="_blank" rel="noopener nofollow">Knee</a> <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> via inhibition of the <a data-href="NLRP3 Inflammasome" href="NLRP3 Inflammasome" class="internal-link" target="_blank" rel="noopener nofollow">NLRP3 Inflammasome</a> in rats who maintain <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels ~ 3.0 mM compared to control rats with BHB levels ~0.4-0.8 mM independent of weight. Ketogenic diet protein composition ~10.9% kcal and control diet protein composition ~18.3% kcal.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-28 19-00-13.md" data-href="Research/Quick Notes/2025-01-28 19-00-13.md" href="Research/Quick Notes/2025-01-28 19-00-13.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 19-00-13</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> can increase the level of the H3K27me3-demethylase <a data-href="JMJD3" href="JMJD3" class="internal-link" target="_blank" rel="noopener nofollow">JMJD3</a></span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Assumptions</span><span class="dataview small-text">2</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-29 09-39-30.md" data-href="Research/Assumptions/2025-01-29 09-39-30.md" href="Research/Assumptions/2025-01-29 09-39-30.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 09-39-30</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The results shown in benjaminFastingInducesHighly2022 - Figure 1C are due specifically to blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels and not to other physiological changes that occur during fasting</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-20 16-49-31.md" data-href="Research/Assumptions/2025-01-20 16-49-31.md" href="Research/Assumptions/2025-01-20 16-49-31.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-20 16-49-31</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> level of mice did not change between day 20 of a <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> and when they were sacrificed post-injury in benjaminFastingInducesHighly2022</span></td></tr></tbody></table></div>

